共 50 条
- [6] Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects Orphanet Journal of Rare Diseases, 12
- [7] Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
- [8] Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (06): : 742 - 755